Pictet Asset Management (UK)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$25.7M Sell
1,055,164
-27,660
-3% -$675K 0.03% 471
2021
Q1
$27.9M Sell
1,082,824
-596,915
-36% -$15.4M 0.03% 434
2020
Q4
$89.8M Sell
1,679,739
-556,124
-25% -$29.7M 0.12% 216
2020
Q3
$92.2M Buy
2,235,863
+184,042
+9% +$7.59M 0.14% 185
2020
Q2
$99.5M Buy
2,051,821
+625,439
+44% +$30.3M 0.17% 167
2020
Q1
$60.3M Buy
1,426,382
+218,707
+18% +$9.24M 0.13% 194
2019
Q4
$51.7M Buy
1,207,675
+237,425
+24% +$10.2M 0.09% 253
2019
Q3
$34.9M Buy
970,250
+611,750
+171% +$22M 0.07% 290
2019
Q2
$9.58M Buy
358,500
+74,700
+26% +$2M 0.02% 526
2019
Q1
$7.62M Buy
283,800
+88,000
+45% +$2.36M 0.02% 579
2018
Q4
$3.17K Buy
195,800
+57,300
+41% +$927 0.01% 744
2018
Q3
$2.88M Sell
138,500
-9,000
-6% -$187K 0.01% 834
2018
Q2
$2.25M Sell
147,500
-554,333
-79% -$8.46M 0.01% 796
2018
Q1
$15.8M Sell
701,833
-719,027
-51% -$16.2M 0.04% 421
2017
Q4
$42.8M Buy
1,420,860
+88,805
+7% +$2.67M 0.11% 245
2017
Q3
$50.2M Buy
1,332,055
+386,217
+41% +$14.5M 0.14% 202
2017
Q2
$24.3M Buy
945,838
+161,600
+21% +$4.15M 0.07% 313
2017
Q1
$27M Sell
784,238
-48,576
-6% -$1.67M 0.09% 291
2016
Q4
$24M Sell
832,814
-97,197
-10% -$2.8M 0.09% 281
2016
Q3
$29.6M Buy
930,011
+95,284
+11% +$3.03M 0.11% 237
2016
Q2
$29.6M Buy
834,727
+523,511
+168% +$18.5M 0.12% 233
2016
Q1
$5.37M Buy
311,216
+72,189
+30% +$1.25M 0.02% 524
2015
Q4
$8.52M Buy
239,027
+91,382
+62% +$3.26M 0.04% 438
2015
Q3
$4.88M Sell
147,645
-104,091
-41% -$3.44M 0.02% 563
2015
Q2
$12.3M Buy
251,736
+147,872
+142% +$7.22M 0.05% 388
2015
Q1
$3.55M Buy
+103,864
New +$3.55M 0.01% 656